NaV channel variants in patients with painful and nonpainful peripheral neuropathy
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received July 25, 2017
- Accepted in final form October 2, 2017
- First Published December 15, 2017.
Author Disclosures
- Samir Wadhawan, PhD,
- Saumya Pant, PhD,
- Ryan Golhar, PhD,
- Stefan Kirov, PhD,
- John Thompson, PhD,
- Leslie Jacobsen, MD,
- Irfan Qureshi, MD,
- Senda Ajroud-Driss, MD,
- Roy Freeman, MD,
- David M. Simpson, MD,
- A. Gordon Smith, MD, FAAN,
- Ahmet Hoke, PhD, MD and
- Linda J. Bristow, PhD On behalf of the Foundation for Peripheral Neuropathy and the Peripheral Neuropathy Research Registry (PNRR) Consortium
- Samir Wadhawan, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
1) Bristol-Myers Squibb, Senior Research Investigator, 2yrs
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Saumya Pant, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
(1)Biocon Bristol-Myers Squibb R&D Centre, India, Associate Research Director, 2016-2017 (2)Bristol- Myers Squibb,Senior Research Investigator, 2014-2016.
NONE
NONE
NONE
NONE
Employee of Bristol-Myers Squibb
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ryan Golhar, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
Bristol-Myers Squibb Senior Research Investigator 3 yrs
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stefan Kirov, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
Bristol Myers Squibb, Principal Research Investigator, 10
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- John Thompson, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
Bristol-Myers Squibb, Research Fellow, 3 years
NONE
NONE
NONE
NONE
Bristol-Myers Squibb
NONE
NONE
NONE
NONE
NONE
NONE
Bristol-Myers Squibb, 3 years
NONE
NONE
- Leslie Jacobsen, MD,
NONE
NONE
NONE
NONE
NONE
NONE
I was a full time employee of Bristol-Myers Squibb during the time that this work was completed.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I was awarded BMS stock during the period that this work was completed
NONE
NONE
- Irfan Qureshi, MD,
NONE
NONE
NONE
NONE
NONE
NONE
Employee of Bristol-Myers Squibb
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Bristol-Myers Squibb
NONE
NONE
- Senda Ajroud-Driss, MD,
1- MT Pharma 2- Alnylam
NONE
NONE
NONE
NONE
hereditary spastic paraplegia, up to date, last updated 7/17
NONE
NONE
MT Pharma
NONE
NONE
Alnylam Viromed
NONE
NONE
Foundation for peripheral neuropathy
NONE
NONE
NONE
NONE
NONE
NONE
- Roy Freeman, MD,
Abide, Acetylon, Astellas, Biogen, Daiichi-Sankyo, Dong, Grace, Grunental, Insys, Lundbeck, Nestle, Novartis, Pfizer, Vertex and Spinifex
NONE
NONE
Autonomic Neuroscience - Basic and Clinical, Editor (2007-2016) Autonomic Neuroscience - Basic and Clinical, Editor-in-Chief (2016-) Clinical Autonomic Research, Editorial Board (1999-present) Clinical Journal of Pain, Assoc. Editor, 2009-2012 Clinical Journal of Pain, Editorial Board (2009-present)
NONE
Royalties from UptoDate
NONE
NONE
NONE
NONE
NONE
(1) Impeto (2) Nestle (3) Pfizer
(1) NIH (NHBLI), R01HL111465-01A1, PI 08/27/13-06/30/17 (2) NIH (NINDS), U54 NS 065736, Co-PI, 09/30/15-06/30/2020
NONE
Multiple system atrophy consortium
(1) Spinifex
NONE
NONE
NONE
NONE
NONE
- David M. Simpson, MD,
Scientific advisory board: Allergan,Merz,Ipsen DSMB: Axsome
NONE
Speaker honoraria: Allergan, Merz, Ipsen
AIDS Patient Care (2008-current)
NONE
Neuropathic Pain: Mechanisms, Diagonosis and Management; Oxford; 2012
Icahn School of Medicine at Mount Sinai
Allergan, Merz, Ipsen
Allergan, Merz, Ipsen
NONE
NONE
Allergan, Merz, Ipsen
NINDS: R01-NS328-05-co-inv; R24 MH59724-co-inv;R01-NS- 41198-co-inv; NIMH-00-AI-0005-co-PI
NONE
Foundation for Peripheral Neuropathy
NONE
NONE
NONE
NONE
NONE
Proctor and Gamble: 2012-2017
- A. Gordon Smith, MD, FAAN,
Celegene Data Monitoring Committee
NONE
NONE
Editor for NeuroLearn
NONE
NONE
NONE
(1) Regenesis (2) Allergan (3) Viromed
NONE
NONE
NONE
(1) Impeto Medical SAS
(1) DK064814 PI 2004-2014 NIDDK (2) U10NS077305 PI 2011-2018 NINDS (3) U10NS086606 CoI 2013-2018 NINDS
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ahmet Hoke, PhD, MD and
NONE
NONE
NONE
Editor-in-Chief, Experimental Neurology Associate editor, Annals of Clinical Translational Neurology
NONE
NONE
Johns Hopkins University, Professor
(1) Neurocrine Inc.
NONE
NONE
NONE
NONE
NIH R01 NS091260 (role: PI); MSCRF MSCRFI-0715 (role: PI); NSF DMR- 1410240 (role: co-investigator); DOD OR160032 (role: PI)
NONE
Foundation for peripheral neuropathy The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
NONE
NONE
NONE
NONE
NONE
National Vaccine Injury Program: gave expert testimony on GBS Arnold & Porter Kaye Scholer LLP: gave expert testimony on peripheral neuropathy
- Linda J. Bristow, PhD On behalf of the Foundation for Peripheral Neuropathy and the Peripheral Neuropathy Research Registry (PNRR) Consortium
NONE
NONE
NONE
NONE
NONE
NONE
(1) Bristol-Myers Squibb, Group Director, 9 years.
NONE
NONE
NONE
NONE
(1) Bristol-Myers Squibb
NONE
NONE
NONE
NONE
NONE
NONE
(1) stock in Bristol Myers Squibb, 2009-present
NONE
NONE
- From the Department of Translational Biomarkers and Computational Genomics (S.W., S.P., R.G., S.K., J.T.), Bristol-Myers Squibb, Hopewell Site, Pennington, NJ; Department of Genetically Defined Diseases Discovery Biology (L.J.B.), Bristol-Myers Squibb, Wallingford, CT; Department of Innovative Clinical Development (I.Q., L.J.), Bristol-Myers Squibb, Lawrenceville, Princeton, NJ; Department of Neurology (S.A.-D.), Northwestern Medical Faculty Foundation, Chicago, IL; Department of Neurology (R.F.), Beth Israel Medical Center, Harvard School of Medicine, Boston, MA; Department of Neurology (D.M.S.), Icahn School of Medicine at Mount Sinai Medical Center, New York, NY; Department of Neurology (A.G.S.), University of Utah School of Medicine, Salt Lake City, UT; Department of Neurology (A.H.), Johns Hopkins University, Baltimore, MD. S.P. is currently affiliated with Biocon Bristol-Myers Squibb Research Center, Bangalore, India.
- Correspondence to Dr. Bristow: Linda.Bristow{at}Sunovion.com
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.